Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-26 @ 12:33 AM
Study NCT ID:
NCT01558960
Status:
TERMINATED
Last Update Posted:
2015-08-20
First Post:
2012-03-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intravitreal Injections of Melphalan for Retinoblastoma
Sponsor:
Hadassah Medical Organization
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
RB-001-HMO-CTIL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None